After a record year in health tech investment with more than $40bn raised in 2021, market corrections, the Russian invasion of Ukraine, and continued supply chain issues are contributing to uncertainty for investors and start-ups in 2022.
Though investor appetite remains strong for solutions seen as transformational to the overall health care ecosystem – including use of...








